TAFAZZIN NM_000116.5(TAFAZZIN):c.697C>T (p.Gln233Ter)

CI-VAR-00121374Explore in graph →p.Gln233TerNM_000116.5:c.697C>TClinVar 662186 rs1603381860

Curated evidence

Evidence by cancer (0 items)

Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.

Data not yet available

No curated evidence item references this variant yet.

ClinVar

Clinical significance (1)

ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.

clinvarCurated1 interpretation · review status and star rating as assigned by ClinVar.

Variation	Clinical significance	Review status	Stars	Conditions	Origin	Submitters	Last evaluated	Source
662186	Pathogenic	criteria provided, single submitter	1	3-Methylglutaconic aciduria type 2; TAFAZZIN-related disorder; Thyroid cancer, nonmedullary, 1	germline	3	Dec 22, 2018	clinvar